| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 06:46:42 UTC |
|---|
| Update Date | 2021-09-26 23:00:59 UTC |
|---|
| HMDB ID | HMDB0249865 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine |
|---|
| Description | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine, also known as CGS 15943A, belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Based on a literature review a significant number of articles have been published on 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine. This compound has been identified in human blood as reported by (PMID: 31557052 ). 9-chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | NC1=NC2=C(C=C(Cl)C=C2)C2=NC(=NN12)C1=CC=CO1 InChI=1S/C13H8ClN5O/c14-7-3-4-9-8(6-7)12-17-11(10-2-1-5-20-10)18-19(12)13(15)16-9/h1-6H,(H2,15,16) |
|---|
| Synonyms | | Value | Source |
|---|
| CGS 15943a | ChEBI | | CGS-15943 | ChEBI | | CGS15943 | ChEBI | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine | ChEBI |
|
|---|
| Chemical Formula | C13H8ClN5O |
|---|
| Average Molecular Weight | 285.69 |
|---|
| Monoisotopic Molecular Weight | 285.0417376 |
|---|
| IUPAC Name | 9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine |
|---|
| Traditional Name | 9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | NC1=NC2=C(C=C(Cl)C=C2)C2=NC(=NN12)C1=CC=CO1 |
|---|
| InChI Identifier | InChI=1S/C13H8ClN5O/c14-7-3-4-9-8(6-7)12-17-11(10-2-1-5-20-10)18-19(12)13(15)16-9/h1-6H,(H2,15,16) |
|---|
| InChI Key | MSJODEOZODDVGW-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazanaphthalenes |
|---|
| Sub Class | Benzodiazines |
|---|
| Direct Parent | Quinazolinamines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Quinazolinamine
- Triazolopyrimidine
- Aryl chloride
- Aryl halide
- Pyrimidine
- Benzenoid
- Azole
- Furan
- Heteroaromatic compound
- 1,2,4-triazole
- Triazole
- Oxacycle
- Azacycle
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 12.1468 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.22 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1697.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 326.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 125.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 199.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 124.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 402.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 622.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 141.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 869.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 375.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1173.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 290.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 368.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 396.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 232.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 76.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,1TMS,isomer #1 | C[Si](C)(C)NC1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12 | 2840.2 | Semi standard non polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,1TMS,isomer #1 | C[Si](C)(C)NC1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12 | 2728.0 | Standard non polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,1TMS,isomer #1 | C[Si](C)(C)NC1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12 | 4154.5 | Standard polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,2TMS,isomer #1 | C[Si](C)(C)N(C1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12)[Si](C)(C)C | 2780.0 | Semi standard non polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,2TMS,isomer #1 | C[Si](C)(C)N(C1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12)[Si](C)(C)C | 2829.3 | Standard non polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,2TMS,isomer #1 | C[Si](C)(C)N(C1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12)[Si](C)(C)C | 3656.2 | Standard polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12 | 2995.6 | Semi standard non polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12 | 2894.9 | Standard non polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12 | 4112.0 | Standard polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12)[Si](C)(C)C(C)(C)C | 3078.1 | Semi standard non polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12)[Si](C)(C)C(C)(C)C | 3178.7 | Standard non polar | 33892256 | | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC2=CC=C(Cl)C=C2C2=NC(C3=CC=CO3)=NN12)[Si](C)(C)C(C)(C)C | 3631.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-2090000000-6a217d422bad494802cd | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine 35V, Negative-QTOF | splash10-001i-0190000000-0a2d73866c1890e2dd6f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine 35V, Positive-QTOF | splash10-000i-0390000000-483f06a0af10080f6b21 | 2021-09-20 | HMDB team, MONA | View Spectrum |
|
|---|